News EU probes Aspen price gouging allegations Aspen pulled drugs from some countries that rejected price hikes, says EU.
News GSK sells anaesthetics portfolio to Aspen Companies also end collaboration in sub-Saharan Africa.
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
